Citation
Boahen, Angela
(2023)
Antibiofilm effects of Limosilactobacillus reuteri 29A cell-free supernatant against major Candida species in murine model of vulvovaginal candidiasis.
Masters thesis, Universiti Putra Malaysia.
Abstract
Postbiotics are metabolites secreted from live microorganisms in their cell-free
supernatants and are strain dependent. They can mimic the beneficial
therapeutic effects of probiotics while avoiding the risk of administering live
microorganisms, coupled with having longer shelf-life. Lactic acid bacteria (LAB)
such as Lactobacillus species which are commonly employed as probiotics, are
native members of a healthy vaginal microbiota, and their dominance is crucial
for an eubiotic vaginal ecosystem. They confer protection through various
mechanisms including production of postbiotics. One of the major disorders
affecting vaginal health is vulvovaginal candidiasis (VVC) and its reoccurrence,
caused by Candida species including Candida albicans and Candida glabrata.
The aforementioned Candida species, notably C. albicans is a biofilm producing
pathogen and habitually forms part of the vaginal microbiota. Latest research
has implicated the role of fungal biofilms in VVC, particularly in the setting of
treatment failure and recurrence. Hence, in this study, we aimed to evaluate the
antibiofilm activity of postbiotics produced by Limosilactobacillus reuteri 29A, in
vitro and in VVC murine model. The cell-free supernatant (CFS) was derived
from fresh 48 h anaerobically cultured L. reuteri 29A strain in De Man, Rogosa
and Sharpe (MRS) broth. It was filter sterilized before introducing to preformed
biofilms of C. albicans (ATCC 14053), C. glabrata (ATCC 2001) reference
isolates and C. albicans (S.21), C. glabrata (95670) clinical isolates. Specifically,
L. reuteri 29A CFS destroyed 91% of C. albicans ATCC 14053 and 92% of C.
albicans S.21 biofilms. For C. glabrata isolates, L. reuteri 29A CFS inhibited 86%
of ATCC 2001 and 83% for C. glabrata 95670 biofilms. The mechanism of the
CFS was dependent on its low pH level. Metabolites produced in L. reuteri 29A
CFS were identified by Gas Chromatography-Mass Spectrophotometry.
Scanning electron microscopy (SEM) displayed the destruction of preformed
biofilms and impediment of C. albicans morphogenesis after postbiotics
administration in vitro. The present study also aimed to investigate the role of the
CFS in VVC murine model. BALB/c female mice were inoculated intravaginally
with cell suspensions of the clinical isolates of Candida species before treatment
with L. reuteri 29A CFS. Microbiological and cytological examinations revealed
that C. albicans yeast to hyphae formation was inhibited and prohibited after L.
reuteri 29A CFS administration, via eliciting the hosts immune response.
Histopathological examination revealed the formation of Candida species
biofilms on the vagina epithelium. However, after treatment with L. reuteri 29A
CFS, desecrated vaginal tissues were restored through Candida species biofilm
inhibition. SEM in vivo further displayed the reinstatement of a bacterial
microflora. Colony forming unit count showed the reduction of fungal burden in
infected mice after L. reuteri 29A CFS administration. Although the efficacy of
the postbiotics L. reuteri 29A has been proven in in vitro and murine model, its
limitation includes its application among human subjects. Overall, the results of
this study demonstrate the potential use of the postbiotics of L. reuteri 29A as an
adjuvant to treat and/or prevent Candida related vaginal infections.
Download File
Additional Metadata
Actions (login required)
 |
View Item |